Data compiled by Redley Lamar · ChainSifter Intelligence
10Suppliers
7Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
Nautilus Biotechnology, Inc. (NAUT) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
21Total relationships
4Distinct source URLs
11High confidence
0.800Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Reciprocal relationship from AMGN graph: Reciprocal relationship from NAUT graph: In October 2021, we entered into a research collaboration agreement with Amgen in which the Nautilus platform may be …
GENENTECH
GENENTECH
90%
In December of 2020, we signed a research collaboration agreement with Genentech to engage in a pilot study using our technology
SINGLE-SOURCE-SUPPLIERS
SINGLE-SOURCE-SUPPLIERS
90%
The Company relies on single source suppliers for certain components and materials used in the Nautilus Voyager TM platform.
THE-BUCK-INSTITUTE-FOR-RESEARCH-ON-AGING
THE-BUCK-INSTITUTE-FOR-RESEARCH-ON-AGING
90%
In February of 2025, we entered into a research collaboration with The Buck Institute for Research on Aging where the Nautilus platform may be used across a number of projects
THE-UNIVERSITY-OF-TEXAS-MD-ANDERSON-CANCER-CENTE
THE-UNIVERSITY-OF-TEXAS-MD-ANDERSON-CANCER-CENTE
90%
In October 2021, we signed a research agreement with The University of Texas MD Anderson Cancer Center
VENDORS
VENDORS
90%
The Company relies, and expects to continue to rely, on a number of vendors to provide services, supplies and materials related to its research and development programs.
Reciprocal relationship from BDX graph: Reciprocal relationship from NAUT graph: stems will provide. We aim to build long-term loyalty with our customers by enhancing their individual research progra…
stems will provide. We aim to build long-term loyalty with our customers by enhancing their individual research programs, enabling their successes, and driving growth within their organizations throu…
Reciprocal relationship from LAB graph: Reciprocal relationship from NAUT graph: Reciprocal relationship from LAB graph: Reciprocal relationship from NAUT graph: Reciprocal relationship from LAB grap…
Reciprocal relationship from BDX graph: Reciprocal relationship from NAUT graph: Reciprocal relationship from BDX graph: Reciprocal relationship from NAUT graph: oyager instrument automates the Nauti…
oyager instrument automates the Nautilus assay chemistry concurrent with rapid optical imaging of the flow cell. The current system is an early-stage design, used for optimization of the function and…
r; (SCIEX); Becton, Dickinson and Company; Quanterix; and Illumina, Inc. (through its acquisition of the former Somalogic business from Standard Biotools Inc.). We also compete with a number of emerg…
Reciprocal relationship from LAB graph: Reciprocal relationship from NAUT graph: Reciprocal relationship from LAB graph: Reciprocal relationship from NAUT graph: Reciprocal relationship from LAB grap…
ARYA-MAKO-MERGER-SUB-INC
ARYA-MAKO-MERGER-SUB-INC
62%
atform. During this phase, we plan to provide early access to our collaborators with broad-scale and targeted analyses and profiling of samples analyzed in our facility and shared via a cloud platfor…
ARYA-SCIENCES-ACQUISITION-CORP
ARYA-SCIENCES-ACQUISITION-CORP
62%
atform. During this phase, we plan to provide early access to our collaborators with broad-scale and targeted analyses and profiling of samples analyzed in our facility and shared via a cloud platfor…
COMPANY-LLC
COMPANY-LLC
62%
nded December 31, 2024, compared to $28.9 million for the year ended December 31, 2023, an increase of $2.1 million, or 7%. The increase was primarily due to a $0.8 increase in professional services …
Nautilus Biotechnology, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
NAUT-DEBT-11170
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2021-12-31.
NAUT-DEBT-11169
Warrants outstanding: 0
90%
xbrl warrant detail from xbrl 2021-12-31.
NAUT-DEBT
Debt stack $28.9M
90%
Market cache reports total debt of $28.9M.
Nautilus Biotechnology, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Nautilus Biotechnology, Inc..
Nautilus Biotechnology, Inc. Ownership
Holder
Name
Confidence
Evidence
NAUT-OWNER-PERCEPTIVE-ADVISORS-LLC
PERCEPTIVE ADVISORS LLC
90%
13F overlay lists PERCEPTIVE ADVISORS LLC as top holder; 84 tracked holders.
Nautilus Biotechnology, Inc. Extended Supply Chain Network
